# Pharmacometric Analysis of Cafedrine/Theodrenaline Versus Ephedrine on Maternal Hemodynamics and Neonatal Acidosis During Cesarean Section

## TL;DR

This study compares how two drugs, cafedrine/theodrenaline and ephedrine, affect blood pressure in mothers and acid-base balance in newborns during cesarean sections.

## Contribution

The study introduces a pharmacometric comparison of two antihypotensive drugs using population kinetic/pharmacodynamic modeling.

## Key findings

- Ephedrine caused a 15% higher maximum heart rate compared to cafedrine/theodrenaline.
- Neonatal acid-base biomarkers were linked to maternal MAP duration, gestational age, and maternal MAXHR.
- Higher maternal MAXHR correlated with lower neonatal base excess, suggesting potential benefits of lower peak heart rates.

## Abstract

Background/Objectives: Ephedrine and cafedrine/theodrenaline (C/T) are established treatments for spinal anesthesia-induced hypotension during cesarean section. Both aim to stabilize maternal blood pressure and enhance neonatal oxygenation. We compared their effects on maternal hemodynamics and neonatal acid-base status using population kinetic/pharmacodynamic (K/PD) modeling and multiple regression analysis. Methods: The multicenter, prospective, open-label, two-armed, non-interventional HYPOTENS study included 243 parturients undergoing spinal anesthesia for elective cesarean section in Germany. Hypotension was treated with intravenous boluses of either C/T (10–200 mg, 55.6%) or ephedrine (5–40 mg, 44.4%), with dosing determined by the attending anesthesiologist. Maternal mean arterial pressure (MAP), systolic blood pressure (SBP), and heart rate (HR) were recorded for 30 min after treatment. Neonatal acidosis biomarkers included umbilical arterial pH, base excess (BE), and lactate. Results: A population K/PD model captured an initial increase followed by a plateau in MAP, SBP and HR after treatment. Maximum HR (MAXHR) was 15% higher after ephedrine than after C/T (p < 0.001). BMI and spinal block height significantly influenced maternal hemodynamics (both p < 0.001). Neonatal biomarkers were associated with the duration of maternal MAP below pre-surgery levels, gestational age, spinal block height, antihypotensive treatment, bupivacaine dose, and MAXHR (all p < 0.05). Conclusions: Ephedrine was associated with higher maternal MAXHR. Notably, higher maternal MAXHR was correlated with lower neonatal BE, suggesting that lower maternal peak HR may benefit. These findings may support the use of substances that are largely inert with respect to maternal HR.